In this groundbreaking presentation from the 8th World Congress of Laparoscopic Surgeons (WALS 2025), Dr. Robert Rutledge, the visionary inventor of the Mini Gastric Bypass (MGB), introduces the world to MGB-2—a refined and innovative advancement in metabolic and bariatric surgery. This video captures the essence of his thought-provoking session, where he outlines the technical enhancements, physiological advantages, and long-term impact of MGB-2 in the treatment of obesity and metabolic disorders.

What is MGB-2?

MGB-2, or Mini Gastric Bypass–Version 2, is a next-generation procedure built on the solid foundation of the original MGB, a technique that revolutionized weight-loss surgery with its simplicity, effectiveness, and safety profile. With MGB-2, Dr. Rutledge presents modifications to gastric pouch construction, anastomosis configuration, and anti-reflux strategy, aiming to improve patient outcomes while minimizing complications such as bile reflux, marginal ulcers, and malabsorption.

Highlights of the Video Presentation

Refinements in Surgical Technique

MGB-2 introduces a more controlled gastric pouch length, improved limb measurement, and modifications that reduce bile reflux incidence. Dr. Rutledge demonstrates how these changes contribute to greater patient tolerance and faster recovery.

Metabolic Impact and Diabetes Remission

He discusses emerging evidence supporting the enhanced metabolic benefits of MGB-2, particularly in improving glycemic control, insulin sensitivity, and long-term remission of Type 2 Diabetes Mellitus, even in lower BMI patients.

Safety and Efficacy

With data from recent clinical trials and follow-ups, Dr. Rutledge explains how MGB-2 is associated with reduced operative time, fewer complications, and sustained weight loss comparable to or better than Roux-en-Y gastric bypass (RYGB).

Global Acceptance and the Future of Bariatric Surgery

MGB-2 is positioned as a procedure for the next generation of bariatric surgeons, offering a balance of technical ease, scalability in surgical settings, and reproducible outcomes—key factors in its growing international adoption.

Dr. Rutledge’s Vision at WALS 2025

Delivering this lecture to a global audience of leading laparoscopic and robotic surgeons, Dr. Rutledge emphasizes the importance of innovation with responsibility. He encourages the adoption of MGB-2 within ethical practice, patient selection guidelines, and institutional frameworks that ensure safety and follow-up.

Conclusion

This video is a must-watch for bariatric surgeons, surgical trainees, and healthcare professionals involved in obesity management. "MGB-2: The Next Evolution in Metabolic and Bariatric Surgery" not only showcases the surgical brilliance of Dr. Robert Rutledge but also marks a significant step forward in the global fight against obesity and related metabolic diseases.

Watch the full video to witness how MGB-2 is shaping the future of bariatric surgery, and how WALS 2025 continues to be a platform for surgical innovation and global collaboration.
Don’t forget to like, comment, and subscribe to stay updated with more insights from the leaders of minimally invasive surgery.